- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/63 - One oxygen atom
Patent holdings for IPC class C07D 213/63
Total number of patents in this class: 141
10-year publication summary
|
8
|
8
|
3
|
9
|
5
|
4
|
6
|
3
|
15
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7819 |
5 |
| Bristol-myers Squibb Company | 4751 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 874 |
4 |
| Nikang Therapeutics, Inc. | 108 |
4 |
| Shanghai Runshi Medical Technology Co., Ltd | 17 |
4 |
| Monsanto Technology LLC | 8578 |
3 |
| InterMune, Inc. | 47 |
3 |
| Versitech Limited | 282 |
3 |
| Ganymede Oncology, Inc. | 6 |
3 |
| Bayer Intellectual Property GmbH | 2363 |
2 |
| Dow AgroSciences LLC | 1185 |
2 |
| Battelle Memorial Institute | 2601 |
2 |
| Board of Trustees of Southern Illinois University | 102 |
2 |
| Cytokinetics, Inc. | 251 |
2 |
| Daewoong Pharmaceutical Co., Ltd. | 366 |
2 |
| FMC Corporation | 806 |
2 |
| Global Blood Therapeutics, Inc. | 168 |
2 |
| Human Biomolecular Research Institute | 20 |
2 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3332 |
2 |
| NATCO Pharma Limited | 204 |
2 |
| Other owners | 86 |